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Abstract
The role of dietary phyto-oestrogens in health has been of continued interest and debate, but data available on the distribution of intake in the Australian
diet are scarce. Therefore, we aimed to estimate phyto-oestrogen consumption in Australian women, describe the pattern of intake and identify correlates of
high phyto-oestrogen intake. Study participants were 2078 control women (18–79 years) from two population-based case–control studies on gynaecological
cancers (2002–2007). Dietary information was obtained using a 135-item FFQ, and the intakes of isoflavones, lignans, enterolignans and coumestans,
including their individual components, were estimated using a database of phyto-oestrogen content in food developed in the UK. Median total intake
(energy-adjusted) of phyto-oestrogens was 1·29 mg/d, including 611 µg/d isoflavones, 639 µg/d lignans, 21 µg/d enterolignans and 8 µg/d coumestrol.
Both isoflavone and lignan intakes were strongly skewed towards higher values and positively correlated with age. Women consumed on average two ser-
vings of soyabean foods/week. Compared to lower phyto-oestrogen consumers (≤1·29 mg/d, median split), higher phyto-oestrogen consumers (>1·29
mg/d) were slightly older, less likely to be smokers, had a higher educational and physical activity level, lower BMI, lower intake of dietary fat, and higher
intake of fibre, selected micronutrients and soyabean foods (all P < 0·03). The daily intake of phyto-oestrogens in Australian women with predominantly
Caucasian ethnicity is approximately 1 mg; this is similar to other Western populations, but considerably lower than that among Asian women. However,
those with a relatively high phyto-oestrogen diet seem to have a healthier lifestyle and a more favourable dietary profile compared to others.
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In the recent past, there has been considerable interest in diet-
ary phyto-oestrogens and their potential health benefits or
risks(1). Phyto-oestrogens have been suggested to play a role
in chronic disease occurrence(2–5), specifically to influence
the risk of hormone-sensitive cancers due to their oestrogenic
and anti-oestrogenic properties(6–12). Apart from their hormo-
nal activities, phyto-oestrogens have been shown to have
antioxidative, antiproliferative, anti-angiogenic and anti-
inflammatory activities(12,13).
Phyto-oestrogens are widespread polyphenolic plant com-
pounds and can be subdivided into three main classes: isofla-
vones, lignans and coumestans(2,4,13). Soyabeans and their
products, and chick-peas are the predominant source of isofla-
vones (genistein, daidzein and glycitein), while oilseeds, whole
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LARI, lariciresinol; MAT, matairesinol; PINO, pinoresinol; SECO, secoisolariciresinol.
*Corresponding author: Dr Petra H Lahmann, fax +61 7 3845 3503, email PLahmann@gmx.de
© The Author(s) 2012. The online version of this article is published within an Open Access environment subject to the conditions of the Creative
Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>. The written permission of
Cambridge University Press must be obtained for commercial re-use.
JNS
JOURNAL OF NUTRITIONAL SCIENCE
1
grains, legumes, vegetables and berries are common food
sources of the more ubiquitous lignans (secoisolariciresinol
(SECO), matairesinol (MAT), lariciresinol (LARI) and pinore-
sinol (PINO)), components of the plant cell wall. Coumestans,
of which coumestrol is the main compound consumed by
humans, occur predominantly during germination in sprouting
legumes. A common feature of many phyto-oestrogens is that
their biological activity depends on intestinal bacterial metab-
olism(6,14). Intestinal gut microflora form the mammalian lig-
nans (‘enterolignans’), enterodiol and enterolactone, from
inactive plant lignans and possibly other plant precursors.
Another metabolite, equol, is produced from the isoflavone
daidzein by intestinal bacteria, but this process happens in
only about one-third of the population(6,12).
Consumption of phyto-oestrogen-rich foods differs across
populations. Soyabean-based foods have long been a staple of
Asian diets and the average dietary intake of isoflavones ranges
from 5 to 80 mg/d(12,13,15), whereas in Western populations the
reported daily intake is usually 1–3 mg or even less(1,11–13,16,17).
Foods commonly consumed in Western societies contain only
small amounts of phyto-oestrogens and these largely comprise
lignans derived from grain products and beverages. Thus the
lignans are usually the most abundant phyto-oestrogens in
the Western diet. Differences in the pattern of phyto-
oestrogen intake and associated lifestyle factors may affect the
potential benefits from this dietary intake on chronic disease
prevention.
In Australia, population-based data on phyto-oestrogen
intake are scarce. To date, only two small studies (n < 500)
have examined dietary intake from isoflavone-rich foods(18)
and intakes of isoflavone and lignan phyto-oestrogens(19).
The assessment and accurate quantification of intake of total
phyto-oestrogens and their components are complex and
rely on comprehensive food databases which have not been
available until recently.
The aims of our study were to estimate intake of phyto-oes-
trogens, including major phyto-oestrogen subclasses and com-
ponents, from food sources among Australian women, by
using a comprehensive database from the European
Investigation into Cancer and Nutrition (EPIC)-Norfolk,
UK. Secondly, we aimed to describe women’s pattern of
phyto-oestrogen intake and, further, to identify socio-
demographic, lifestyle and dietary factors which are correlated
with higher phyto-oestrogen intake from food sources.
Methods
Study population
Study participants were control women from two population-
based case–control studies conducted in Australia: the
Australian Ovarian Cancer Study (AOCS, 2002–5) and the
Australian National Endometrial Cancer Study (ANECS,
2005–7). Controls, aged 18–79 years, were randomly selected
from the National Electoral Roll (enrolment to vote is compul-
sory in Australia), and frequency matched to cases with ovar-
ian or endometrial cancer by age (in 5-year groups) and state of
residence. Full details of the AOCS and ANECS study recruit-
ment and data collection have been reported previously(20,21).
This study was conducted according to the guidelines laid
down in the Declaration of Helsinki and all procedures invol-
ving human subjects/patients were approved by the
Queensland Institute of Medical Research Human Research
Ethics Committee and all relevant hospital and Cancer
Registry Human Research Ethics Committees. Written
informed consent was obtained from all female subjects/
patients.
Of the 3442 eligible control women contacted in AOCS,
1615 (47 %) consented to participate. Women who reported
previous bilateral oophorectomy or did not answer the main
questionnaire were excluded, leaving 1508 women. Of the
1404 eligible control women with no report on prior hyster-
ectomy contacted in ANECS, 740 (53 %) agreed to participate
and completed an interview. For the present study, we
additionally excluded ninty-three AOCS and seventy-seven
ANECS control women who did not return a FFQ or
did not have valid data on energy intake (≤2940 kJ/d or
≥16 800 kJ/d), leaving a final group of 2078 women (1415
AOCS; 663 ANECS) for this analysis. Caucasian ethnicity
was reported by 96 % of all women.
Dietary assessment
Dietary information was obtained using a 135-item semi-
quantitative FFQ based on the instrument developed by
Willett et al.(22), and modified and validated for use in
Australia(23–25). Reasonable reproducibility of food and nutri-
ent intake for this FFQ has been documented(26). Women
were asked to report on how often they consumed a specified
amount of each food item (including items on alcohol con-
sumption) in the previous year.
The FFQ included the following soyabean food items: soya-
beans, soyabean milk, soyabean-based meat substitutes and
soyabean and linseed bread. For each food, a commonly
used unit or portion size was specified, and women were
asked to estimate how often, on average, they had eaten the
given amount of food over the past year. The nine response
options ranged from ‘never’ to ‘four or more times per day.’
Women also provided detailed information on the consump-
tion of nutritional supplements.
Average daily intake of phyto-oestrogens was calculated by
multiplying the estimated intake of each food item in g/d
(based on the frequency of consumption and average portion
size), by the phyto-oestrogen content of the food using a com-
prehensive database developed in the UK(10). This database
covered more than 500 UK food items which were analysed
for twelve phyto-oestrogens and lignans in triplicate by
means of LC/MS/MS and 13C3-labelled internal standards
as described previously(27,28). Specifically, phyto-oestrogens
in foods of animal origin are included in this database(29).
For nine food items which were not found in the UK data-
base, a recipe approach was used to estimate phyto-oestrogen
intakes. Similar to the UK(10,30), soyabean is also used in the
production of bread in Australia to help improve the bread
quality. We compared published data on the isoflavone
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content of bread, soyabean and soyabean products in
Australia(31) with the UK database and found the values to
be compatible. Plant lignan intake in the UK database was
based on SECO and MAT only. The values for LARI and
PINO were derived from a published Canadian database(32).
The intakes (μg/d) of the following phyto-oestrogens from
food sources were estimated: isoflavones (daidzein, genistein,
glycitein, biochanin A and formononetin), lignans (SECO,
MAT, LARI and PINO), enterolignans (enterolactone,
enterodiol and equol), coumestrol and total phyto-oestrogens.
Equol, a metabolite of daidzein, is not a mammalian lignan,
but was included in the subclass of enterolignans because it
is formed by intestinal microflora, as is enterodiol and entero-
lactone(10). Plant lignans are considered to be precursors of
their bioactive form and hence precursors of phyto-
oestrogens. In this study, as commonly done by others, we
refer to as phyto-oestrogens the group of polyphenolic plant
compounds including both active and inactive forms of lig-
nans and isoflavones. The daily intake of energy (kJ/d),
macronutrients (g/d), vitamins and minerals (mg or μg/d)
was estimated using Australian food composition tables as
contained in NUTTAB2006(33).
Covariates
Women self-completed a questionnaire (AOCS) or were inter-
viewed in person (ANECS) on health and lifestyle character-
istics(20,21) including ethnicity (Caucasian, Asian and others),
marital status (single, separated and married), education
(high school or less, technical college/diploma, trade certifi-
cate/apprenticeship and university), occupation (employed
full-time/part-time/retired/unemployed), smoking status
(never/ex-/current smoker), alcohol consumption (g/d), rec-
reational physical activity (low, moderate and high level
based on the frequency and intensity of activity per
week)(34), body size, menopausal status (pre-/peri-/postmeno-
pausal), age at menopause (years), parity (nulliparous/parous),
and ever use of oral contraceptives (yes/no) and hormone
replacement therapy (yes/no). Women were asked to report
their height and weight 1 year before study recruitment.
BMI was calculated as weight (kg) divided by height (m)
squared, and categorised according to commonly used defi-
nitions of overweight and obesity(35).
Statistical analysis
For all analyses, we used a pooled dataset of participants (n
2078) from both studies AOCS and ANECS. Women partici-
pating in AOCS (n 1415, 19–79 years) did not differ signifi-
cantly from those participating in ANECS (n 663, 31–79
years) on relevant characteristics, except for age and parity.
On average, women from ANECS were older than their
counterparts from AOCS (mean age: 61·1 (SD 9·8) v. 56·3
(SD 12·5) years), and were less likely to be nulliparous (8 v.
12 %). In contrast to AOCS, ANECS by study design included
only women who reported no prior hysterectomy.
Intake estimates of dietary phyto-oestrogens were adjusted
for total energy intake using the nutrient residual method as
described by Willett(22). All dietary variables were log-
transformed prior to calculation of the residuals. Women
were categorised as lower than median (≤1286 µg/d) or
higher than median (>1286 µg/d) phyto-oestrogen consu-
mers, based on the median energy-adjusted daily intake of
total phyto-oestrogens, and are referred to as ‘lower’ and
‘higher’ consumers throughout the article. Daily (weekly)
soyabean consumers were defined as women who consumed
at least one portion of any of the following foods per d
(week): soyabeans, soyabean milk, soyabean-based meat sub-
stitutes and soyabean and linseed bread. For lower v. higher
phyto-oestrogen consumer comparisons, a χ2 test was applied
to categorical variables and a Student’s t test was conducted
for continuous variables. ANOVA was used to determine
differences in dietary intake between lower and higher
phyto-oestrogen consumers adjusted for age, education, par-
ity, BMI, physical activity and the use of any dietary sup-
plement. We used Spearman correlations to assess the
relation between phyto-oestrogen variables and relevant
cofactors. Data were analysed using the SAS statistical pack-
age (version 9.2; SAS Institute). All statistical tests were two-
sided, and P values <0·05 were considered significant.
Table 1. Daily energy and specific phyto-oestrogen intakes from FFQ in
Australian women, 18–79 years (n 2078)





Energy (kJ) 9004 2538 8763 3375
Percentage of energy
from fat
31·3 5·5 31·2 7·0
Percentage of energy
from carbohydrates
44·3 6·3 44·5 7·7
Percentage of energy
from protein
18·8 3·0 18·6 3·9
Unadjusted intakes (µg)
Total phyto-oestrogens 3580·5 6755·2 1334·6 1823·7
Isoflavones 2826·7 6616·5 604·0 1475·6
Lignans 718·3 370·5 644·3 390·6
Enterolignans 23·1 14·1 20·1 17·5
Coumestrol 12·4 18·0 7·9 7·0
Energy-adjusted intakes*
(µg)
Total phyto-oestrogens 3293·0 5770·8 1285·8 1693·3
Isoflavones 2556·3 5749·0 610·5 1488·5
Daidzein 768·3 1717·3 197·3 452·5
Genistein 1637·9 3822·0 344·9 953·8
Glycitein 124·5 227·3 41·1 81·0
Biochanin A 21·9 9·0 19·7 9·1
Formononetin 3·7 1·8 3·2 1·6
Lignans 692·9 296·4 639·0 322·9
Secoisolariciresinol 474·2 243·7 426·1 232·8
Matairesinol 68·8 36·4 58·9 41·6
Pinoresinol 56·6 30·1 51·6 35·1
Lariciresinol 84·9 34·0 80·3 42·8
Enterolignans 22·3 12·4 20·6 15·1
Enterolactone 16·5 9·5 14·9 11·3
Enterodiol 0·05 0·05 0·04 0·05
Equol 5·8 3·2 5·4 3·7
Coumestrol 11·9 16·0 7·8 6·5





Women’s dietary phyto-oestrogen intake (energy-adjusted) is
shown in Table 1. Estimated daily median intake of total
phyto-oestrogens was 1·29 mg (mean 3·4 (SD 5·8) mg) of
which 0·6 mg was derived from isoflavones and 0·6 mg
from lignans. As expected, enterolignans (median intake 21
µg/d) and coumestrol (median intake 8 µg/d) were consumed
in very small amounts. Isoflavone intake ranged from 45 to 71
908 µg/d and was strongly skewed towards higher values
(Fig. 1), as was lignan intake (range: 101–2515 µg/d),
although to a lesser extent (Fig. 2). For the total study sample,
genistein and daidzein contributed most to the isoflavone
intake (88 %), SECO (66 %) most to lignan intake, while
enterolactone (73 %) was the predominant enterolignan.
Of all women, 11 % (30 %) were daily (weekly) soyabean
food consumers, 59 % used dietary supplements and 21 %
used phyto-oestrogen-containing supplements regularly. On
average, women consumed two servings of soyabean foods/
week of which soyabean/linseed bread (1·2 servings/week)
was the dominant soyabean item, followed by soyabean milk
products (0·7 servings/week). Total phyto-oestrogen intake
was positively correlated with age (r 0·07) and negatively cor-
related with BMI (r −0·08) (both P < 0·001). Specifically, lig-
nan intake (r 0·18, P< 0·0001) was more strongly correlated
with age than isoflavone intake (r 0·04, P= 0·06).
Characteristics for women grouped as lower or higher diet-
ary phyto-oestrogen consumers are presented in Table 2.
Higher phyto-oestrogen consumers were slightly older, more
likely to have a higher education and leisure activity level, to
be nulliparous, dietary and phyto-oestrogen supplement
users and daily soyabean food consumers compared to their
counterparts with lower phyto-oestrogen intake.
Furthermore, higher phyto-oestrogen consumers tended to
have a lower mean body weight and BMI and accordingly
were less likely to be overweight or obese than lower phyto-
oestrogen consumers. They were also less likely to be smokers.
Other characteristics were not significantly associated with the
level of phyto-oestrogen intake.
Table 3 gives estimates of daily energy, nutrient and phyto-
oestrogen intake in higher and lower consumers adjusted for
various factors shown to be associated with phyto-oestrogen
intake. On average, women who were defined as lower consu-
mers had a median phyto-oestrogen intake of 0·9 (interquartile
range 0·3) mg/d from diet, whereas higher consumers had a
total median intake of 2·6 (interquartile range 4·6) mg/d.
Of the higher-intake group, 22% consumed soyabean food
on a daily basis (0 % in the lower-intake group). The difference
in phyto-oestrogen consumption was therefore especially large
for isoflavones (median intake 1·8 v. 0·3 mg/d), and less
marked for the other three subclasses. Except for protein,
Ca, Zn and alcohol, intakes of all nutrients were significantly
different between the lower- and higher-intake groups.
Overall, energy-adjusted mean intakes of carbohydrates,
fibre, vitamins and minerals were higher and those of total
and saturated fat were lower in women with a higher phyto-
oestrogen intake, indicating an overall healthier dietary profile.
The more favourable dietary pattern was also reflected in
other eating behaviours assessed by short questions in the
FFQ (data not shown). Higher consumers were more likely
to consume ≥2 servings of fruit (70 %), ≥5 servings of veg-
etables (15 %), or ≥4 servings of cereals (35 %) per d com-
pared to women with lower phyto-oestrogen intake (57, 8·5
and 24 %).
Bread was the major food source of dietary phyto-oestro-
gens in both lower and higher consumers, but this differed
by type for the two groups as indicated in Table 4. In higher
consumers soyabean/linseed bread, soyabean milk and non-
soyabean bread contributed each 12 % or more to the daily
intake of phyto-oestrogens, while non-soyabean bread, veg-
etables (other than soyabeans/legumes) and fruit were the pre-
dominant sources (each >16 %) of phyto-oestrogens among
lower consumers. Among lower consumers, beverages, other
than soyabean milk, provided a moderate contribution to
daily phyto-oestrogen intake, specifically to intakes of lignans
(coffee, tea and wine) and enterolignans (non-soyabean
milk). In a sub-analysis (data not shown), we examined the
contribution of phyto-oestrogen-containing supplements to
Fig. 2. Distribution of dietary lignan intake among 2078 Australian women
(2002–2007).




total phyto-oestrogen intake, including phyto-oestrogens
derived from food sources and supplements. Among users
(21 %) of phyto-oestrogen-containing supplements, sup-
plements contributed only 0·06 (interquartile range 0·17) % to
the total daily intake of phyto-oestrogens.
Discussion
To our knowledge, this investigation is the first to report on the
three main classes of dietary phyto-oestrogens in Australian
women: isoflavones, lignans (and separately enterolignans) and
coumestans, including their components. Two previous much
smaller (n< 476) Australian studies examined isoflavone-rich
foods(18), or total isoflavone and lignan intakes(19) only. In this
cohort of 2078 women, aged 18–79 years, who participated
as controls in two major population-based case–control studies
on gynaecological cancers between 2002 and 2007, we observed
that median intake of total phyto-oestrogens (energy-adjusted)
from dietary sources was slightly over 1 mg/d (1286 (interquar-
tile range 1693) µg/d). Dietary isoflavone intake (median 611
µg/d) was similar to lignan intake (median 639 µg/d), while
the intake of enterolignans (median 21 µg/d) and coumestrol
Table 2. Demographic, lifestyle and reproductive characteristics of Australian women by level of total dietary phyto-oestrogen intake (n 2078)
(Percentages or mean values and standard deviations)
Total phyto-oestrogen intake
Variables Lower (≤1286 µg/d; n 1040) Higher (>1286 µg/d; n 1038) P
Age, categorical (%)
< 45 years 16·5 12·4 0·03
45–59 years 39·5 40·8
≥ 60 years 44·0 46·8
Marital status (%)
Single/never married 5·3 6·8 0·30
Separated 18·6 19·1
Married/de facto 76·1 74·1
Menopausal status (%)
Pre-menopausal 25·3 20·3 0·02
Peri-menopausal 5·8 7·1
Post-menopausal 68·9 72·6




Caucasian 96·2 95·5 0·61
Asian 1·6 2·1
Others 2·2 2·3
Education after high school (%) 47·3 55·1 0·0004
Employment (%)




Nulliparous (%) 8·7 12·3 0·06
Ever use of oral contraceptives (%) 80·2 79·9 0·88








<25·0 kg/m2 42·4 50·9 0·0004
25·0–29·9 kg/m2 32·5 29·1
≥30 kg/m2 25·1 20·0
Smoking status (%)
Never 60·4 58·0 0·02
Past smoker 27·5 32·6
Current smoker 12·1 9·5
Leisure physical activity (%)
Low 20·2 13·4 <0·0001
Medium 39·9 38·2
High 39·9 48·4
Daily soya consumer (%) 0·0 21·9 <0·0001
Use of any dietary supplement (%) 53·3 64·7 <0·0001
Use of phyto-oestrogen supplement (%) 17·9 24·3 0·0003
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(median 8 µg/d) was low. Soyabean foods were the predomi-
nant source of phyto-oestrogens. Overall, women consumed
on average two servings of soyabean foods per week, whereas
among higher phyto-oestrogen consumers, 22 % ate soyabean
foods on a daily basis. Women who were grouped as higher
phyto-oestrogen consumers were somewhat older, had a higher
Table 3. Daily energy and energy-adjusted intakes of selected nutrients and main classes of phyto-oestrogens of Australian women by level of total dietary
phyto-oestrogen intake (n 2078)†
(Mean values and standard deviations; median values and interquartile ranges)
Lower (≤1286 µg/d; n 1040) Higher (>1286 µg/d; n 1038)
Nutrient Mean SD Median Interquartile range Mean SD Median Interquartile range
Energy (kJ) 9110* 2503 8892 3330 8897 2570 8643 3445
Percentage of energy from fat 32·3* 5·4 32·1 6·7 30·3 5·5 30·1 6·8
Percentage of energy from carbohydrate 44·0 6·3 44·0 7·7 44·6 6·2 45·1 7·7
Percentage of energy from protein 18·8 3·1 18·5 3·8 18·8 3·1 18·8 3·9
Energy-adjusted intakes‡
Total phyto-estrogens (µg) 923·4* 224·5 937·4 346·1 5667·6 7440·5 2631·5 4591·0
Isoflavones§ (µg) 349·2* 175·1 315·5 252·4 4767·6 7509·2 1799·6 4248·6
Lignans|| (µg) 541·3* 171·5 528·4 224·9 8447 316·8 775·6 351·0
Enterolignans¶ (µg) 23·4* 12·9 21·0 15·7 21·2 11·8 20·1 14·8
Coumestrol (µg) 9·3* 9·5 6·9 5·6 14·2 20·2 9·1 7·7
Protein (g) 96·9 15·6 95·8 19·5 97·1 15·2 96·2 19·4
Carbohydrate (g) 227·2* 32·3 227·7 49·8 230·2 32·3 230·6 40·1
Fat (g) 74·1* 12·3 73·5 15·7 69·5 12·6 69·3 15·5
Saturated fat (g) 28·5* 6·7 27·8 8·5 24·5 6·4 23·9 7·9
Monounsaturated fat (g) 26·7* 5·3 26·3 6·3 25·4 5·6 25·4 7·1
Polyunsaturated fat (g) 11·7* 2·7 11·2 3·5 12·3 3·2 11·9 3·9
Cholesterol (mg) 268·7* 88·5 256·9 90·2 242·8 79·2 236·0 89·4
Fibre (g) 30·2* 7·4 29·8 9·4 35·7 8·4 34·9 10·4
Alcohol (g) 6·5 9·4 2·4 9·3 8·2 11·4 3·6 10·7
Total folate (µg) 374·5* 115·5 361·3 143·9 401·0 122·8 385·0 143·6
Vitamin C (mg) 173·5* 71·6 161·9 85·9 197·7 78·3 187·7 93·9
β-Carotene (µg) 5388·0* 2422·3 5075·5 3154·7 6547·6 3292·5 5966·4 3610·2
Vitamin E (mg) 7·6* 2·0 7·4 2·7 8·2 2·2 7·9 2·5
Ca (mg) 995·2 349·1 937·7 422·5 1017·5 323·8 982·3 404·4
Fe (mg) 12·7* 2·2 12·6 2·6 13·9 2·4 13·8 2·9
Mg (mg) 360·7* 54·4 360·9 72·5 406·1 55·1 402·2 69·9
Zn (mg) 13·3 2·2 13·1 2·7 13·0 2·2 12·9 2·9
* Mean value was significantly different from that of the higher consumers (P<0·05).
† Adjusted for age, education, parity, BMI, physical activity and use of any dietary supplement.
‡ Adjusted using the residual method; nutrients were log-transformed before adjustment.
§ Including daidzein, genistein, glycitein, biochanin A and formononetin
|| Including secoisolariciresinol, matairesinol, lariciresinol and pinoresinol.
¶ Including enterolactone, enterodiol and equol.
Table 4. Consumption and percentage contribution of food groups to total daily intake of phyto-oestrogens (PE) from food sources in Australian women
grouped under lower and higher PE consumers
Lower consumers (≤1286 µg/d; n 1040) Higher consumers (>1286 µg/d; n 1038)
Food groups g/d Percentage of total PE* g/d Percentage of total PE*
Soyabean and linseed bread 0·3 3·0 9·3 21·8
Soyabean milk 0·07 0·3 51·1 18·6
Non-soyabean bread 46·6 23·2 50·9 11·9
Vegetables not including potatoes, soyabeans and other legumes 285·3 22·5 335·6 10·6
Fruits 515·6 16·1 597·4 8·0
Soyabeans 0·05 0·7 2·6 6·3
Breakfast cereals 56·4 1·3 60·2 4·9
Soyabean-based meat substitutes 0·09 0 3·8 3·8
Coffee 365·0 7·1 426·3 3·6
Tea 461·6 6·0 526·2 2·6
Non-soyabean milk 315·9 4·7 248·4 1·6
Legumes, not including soyabeans 59·2 3·3 63·1 1·6
Wines 51·6 2·4 73·5 1·5
Nuts 5·4 1·8 8·2 0·9
Other dairy products 126·8 2·3 124·9 0·8
Meat, chicken, seafood and eggs 220·3 1·7 198·6 0·5
All other foods† 1138·9 3·6 1092·3 1·0
* Ordered by percentage contribution in higher consumers (total PE >1286 µg/d).
† Includes foods contributing <0·5 % among higher consumers.
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educational level, healthier lifestyle and more favourable dietary
profile compared to the rest of the cohort.
Overall, the isoflavone intake in our study is comparable to
other reports from Western female populations(11–13,16,17,36–40)
with average isoflavone consumption of ≤1 to 2 mg/d. This is
considerably lower than the level found in typical Asian
soyabean-based diets(12,13,15,18,41) and also below levels
where physiological effects are expected (45–100
mg/d)(1,17,42). Notably, the median dietary isoflavone intake
was relatively high when compared to that reported (30 µg/d)
in the Australian Longitudinal Assessment of Ageing in
Women study (n 475, 40–80 years)(19), and more similar to
data from UK women (mean 979 (SD 1859) μg/d) participating
in the EPIC-Norfolk study that used the same phyto-oestrogen
database as the current analysis(11). The low daily median intake
of dietary isoflavones in the Longitudinal Assessment of Ageing
in Women study is unexpected given that this estimate is based
on a 112-item FFQ including thirty soyabean foods, and there-
fore one would expect to see a greater estimated intake of isofla-
vones compared to the FFQ in the present investigation which
contained only five soyabean foods.
In contrast, in the present study, dietary lignan intake was
about 35 % of the amount reported (median 1830 µg/d) for
women in the Australian Longitudinal Assessment of Ageing
in Women study(19). Lignan values from that study were
based on published values for enterolactone and enterodiol,
assessed by an indirect in vitro fermentation assay and thus
include all sources of plant lignans(19,43). Differences in average
intakes may be due to the use of these different assessment
methods and databases. When comparing our data with earlier
studies of women in Europe and North America which based
total lignan intake on either two compounds (SECO and
MAT)(11,13,16,37) or on four compounds (SECO, MAT,
LARI and PINO)(38,44,45) or more(36), average consumption
of plant lignans was compatible and varied between 177 and
1100 µg/d (median). Lignan intake increased with age, which
is in accordance with the findings in Dutch women(45), but
in contrast to other recent Australian data showing no vari-
ation by age(19).
Women’s estimated mean (or median) intake of entero-
lignans derived from foods of animal origin was similar to
levels reported for women (control women for breast cancer
cases) in the EPIC-Norfolk study (enterolactone and equol)
and women (non-cases) in a Swedish breast cancer study
(enterolactone, enterodiol and equol)(8,10). The median intake
of coumestrol (8 µg/d) in our study was slightly higher than
the reported values from other Western countries (all ≤2
µg/d)(8,13,16,36,38,40,44) except for one(39) reporting a mean
intake of coumestrol of 114 µg/d for US women participating
in a prospective breast cancer study.
In contrast to some other Western female popu-
lations(8,13,16,38,40), the average isoflavone intake in this cohort
of women was also high and similar to lignan intake and this is
probably due to the relatively high consumption of soyabean
foods and the soyabean added to bread to improve the
bread quality. One-third of all women reported consumption
of at least one serving of soyabean food per week as estimated
from the FFQ data; among higher phyto-oestrogen consumers
this proportion was almost twice as high (58 %). This com-
pares to 50 % consuming ≥1 serving per week among
Australian-born women (n 390, 51–62 years) participating in
the population-based Melbourne Women’s Midlife Health
study(18) and 40 % consuming ≥1 serving during the past
month in the Longitudinal Assessment of Ageing in Women
study(19). A common feature of these Australian female
cohorts, including ours, is that the most frequently consumed
soyabean food is soyabean/linseed bread with a reported
prevalence of 30–38 %(18,19), and 44 % in the present study.
By contrast, among European women(46) soyabean dairy sub-
stitutes of which 75 % were liquid items were consumed the
most frequently of the seven soyabean product groups exam-
ined. Similarly, other studies from Europe and North America
have identified soyabean products other than bread as the
main soyabean sources for women(38,47–49).
Higher phyto-oestrogen consumers differed significantly
from women who consumed lower levels in other dietary,
socio-demographic and lifestyle factors. In the present study,
increased phyto-oestrogen consumption was associated with
higher education and a healthier lifestyle indicated by lower
smoking prevalence, lower BMI and higher physical activity
level. This is consistent with previous evidence from
some(18,19,45), but not all(48) cross-sectional studies. In the lat-
ter small study of postmenopausal US women (n 96), plasma
isoflavone concentrations were not associated with education,
BMI or activity level. As expected, higher phyto-oestrogen
intake was indicative of a beneficial dietary profile, with per-
centage of energy from fat and fibre closer to current dietary
guidelines and higher intakes of selected vitamins and minerals
from food sources, and this finding is compatible with other
studies(19,45,48). The proportion of users of phyto-oestrogen-
containing supplements was slightly higher among higher
phyto-oestrogen consumers compared to lower phyto-oestro-
gen consumers (24 v. 18 %). However, the contribution from
these supplements to the total daily intake of phyto-oestrogens
(diet and supplement) among users was negligible (<1 %).
Although the cross-sectional design does not provide infor-
mation on causal (temporal) relationships, our findings may
suggest a possible association between dietary phyto-oestrogen
intake and health-related behaviours.
Some limitations of our study warrant consideration. The
participation rate among controls was relatively low in
AOCS (47 %) and ANECS (53 %); hence these women may
not be representative of the Australian female population.
However, previous comparisons of the AOCS controls to
the 2004 Australian National Health Survey, a representative
survey of the Australian adult population(50), have shown
that the distributions of key variables (education level, parity,
BMI and ever/never smoking status) were comparable with
national data(21,51).
The 135-item FFQ used in this study included the most
commonly consumed soyabean-food items in the Australian
diet, but was not designed to specifically investigate intake of
phyto-oestrogens or their respective subclasses. As a result,
consumption of selected foods, such as seeds (important for
lignan intake), was not queried in detail and may have been
underestimated. However, the FFQ was designed to reflect
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dietary intake of Australians, with food groups such as grain
products, fruits and vegetables, which are usually rich in lig-
nans, being well captured(23–25). Establishing the phyto-oestro-
gen content in foods and quantifying dietary isoflavones and
lignans has been challenging and has led to the compilation
of several databases over the last two decades. In this study,
we used a recently developed comprehensive UK database
which allowed for more accurate estimation of phyto-oestro-
gen exposure, including the phyto-oestrogen content of
foods of animal origin(10). Recently, the lignan compounds
LARI and PINO were shown to contribute a higher pro-
portion to the overall lignan intake than SECO and
MAT(45). However, in our study, the inclusion of these two
compounds did not substantially increase the total lignan
intake, and SECO remained the major contributing com-
ponent of plant lignans.
In this cohort, 4 % of women were of Asian or other
non-Caucasian ethnicity, including Indigenous people. As
expected, their average phyto-oestrogen intake was somewhat
higher than that observed for the majority of the cohort,
mainly attributed to increased isoflavone intake (data not
shown). However, ethnicity was not a correlate of phyto-oes-
trogen intake when comparing lower and higher consumers.
In summary, in this population-based cohort of predomi-
nantly middle-aged and older women, the largest Australian
investigation on this topic to date, dietary phyto-oestrogen
intake was similar to levels reported by other Western popu-
lation studies, and substantially lower than that published for
Asian women. Among the subclasses examined, isoflavones
contributed most to the total phyto-oestrogen intake, and simi-
lar to other Australian data soyabean/linseed bread and other
bread were the predominant food source of isoflavones and
plant lignans. This study suggests that dietary phyto-oestrogen
intake, specifically that of plant lignans, is correlated with older
age in women whose age ranged from 18 to 79 years. This
association may reflect a perception that these compounds
are associated with health benefits, such as alleviation of
menopausal symptoms(1), or alternatively a healthier lifestyle
with ageing. Interestingly, women in the present study who
used phyto-oestrogen-containing supplements (21 %) were
on average slightly younger (mean age 57·8 v. 59·0 years)
and more likely to be pre- or peri-menopausal compared to
those not using this type of supplement. This is likely to reflect
the use of supplements during early menopausal transition.
Overall, in this female population, higher phyto-oestrogen
consumption was correlated with higher dietary fibre and
lower fat intake and characteristics indicative of a healthier life-
style such as non-smoking, lower BMI and higher recreational
physical activity level. These factors should be considered as
potential confounding variables or effect modifiers in future
epidemiological research where much of the evidence to
date remains inconclusive regarding the role of dietary
phyto-oestrogens in women’s health.
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